The chemokine IL-8 is critically important in inflammatory processes in human tissues, and IL-8 interactions with sulfated glycosaminoglycans have been implicated in modification of inflammatory responses in bronchial epithelium. To determine the role of chondroitin-4-sulfate (C4S) in mediating effects of IL-8, we silenced the enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B [ASB]) that removes the 4-sulfate group from C4S, in the IB3-1 and C38 bronchial epithelial cell lines and in normal primary bronchial epithelial cells. When ASB was silenced and IL-8 production stimulated by exposure to TNF-a, ASB activity declined by roughly 75%, cellular C4S content increased by over 7.5 mg/mg protein, cellbound IL-8 increased by over 530 pg/mg protein, and secreted IL-8 declined by over 520 pg/mg protein in all cell lines (P , 0.001). When cell lysates were immunoprecipitated with C4S antibody after ASB silencing and TNF-a, the IL-8 content of the immunoprecipitate was approximately 500 pg/mg protein, indicating that most of the cellbound IL-8 was associated with C4S. Cell fractionation demonstrated that the IL-8 content associated with the cell membranes was about twice that of the cytosolic fraction. Also, ASB appeared to localize in the cell membrane, as well as in lysosomes. Neutrophil attraction to the cell lysates increased after ASB silencing, consistent with increased attraction to the cell-bound IL-8. These findings provide evidence for the influential role of ASB and C4S in the regulation of IL-8 secretion, and suggest that changes in ASB activity and C4S content may have a significant impact on IL-8-mediated inflammatory responses.
Interleukin-8 (IL-8) is a critically important mediator of neutrophil attraction and adherence in inflammation. Interactions of glycosaminoglycans (GAGs) with IL-8 have been reported and associated with modulation of cellular responses to inflammation (1) (2) (3) (4) . A low affinity GAG-binding domain of IL-8 that is responsible for interactions with heparin and heparan sulfate has been reported, and specific amino acid substitutions of IL-8 that affect GAG binding and localization in lung tissue, as well as IL-8 dimerization, have been studied (1, 2) . The interaction of the nonsulfated GAG, hyaluronan, with CD44 has also been studied (5, 6) . To elucidate the role of chondroitin-4-sulfation in the IL-8-GAG interaction, we have silenced the enzyme, N-acetylgalactosamine-4-sulfatase (arylsulfatase B [ASB], 4-sulfatase), the enzyme that hydrolyzes the 4-sulfate group from chondroitin-4-sulfate (C4S), and proceeded to examine the impact of ASB silencing on IL-8 localization and function after stimulation by TNF-a.
Because ASB activity has been shown to be diminished in patients with cystic fibrosis (CF) (7) , and ASB activity increases when the CF transmembrane regulator (CFTR) gene is corrected in CF cell lines (8) , we hypothesized that decline in ASB activity might have an impact on inflammatory responses in bronchial epithelial cells (BECs) that was mediated through changes in C4S.
To determine the functional and structural impact of reduced ASB activity, we evaluated the effect of silencing ASB on the IL-8 response to TNF-a stimulation in three types of BECs: the IB3-1 cell line, derived from a patient with CF; the C38 cell line, in which the CFTR defect of the IB3-1 cells was corrected; and normal primary BECs. Because C4S contains, as its fundamental disaccharide unit, D-glucuronate, in combination with N-acetyl-D-galactosamine-4-sulfate, and the substrate for ASB is the sulfate group of N-acetylgalactosamine-4-sulfate at the nonreducing end, we anticipated that decline in ASB activity would lead to increase in chondroitin-4-sulfation, and hypothesized that this increase might have a significant impact on IL-8 localization. Measurements of the total cellular sulfated GAGs (sGAGs) (including C4S, chondroitin-6-sulfate (C6S), dermatan sulfate, heparan sulfate, and heparin) and C4S content were undertaken to demonstrate the effects of ASB silencing, and the interaction of C4S and IL-8 was approached by determining the amount of IL-8 that coimmunoprecipitated with C4S. We suggest that reduced ASB activity in CF leads to the accumulation of sGAGs, particularly C4S, and that the C4S-IL-8 interaction may be responsible, at least in part, for the altered inflammatory responses that are pathognomonic of CF.
MATERIALS AND METHODS

Cell Culture of BECs
The BEC lines, C38 and IB3-1 (American Type Culture Collection, Johns Hopkins Collection, Manassas, VA) were grown in flasks or plates coated with human fibronectin (10 mg/ml; Sigma-Aldrich, St. Louis, MO), collagen (30 mg/ml; Sigma-Aldrich), and BSA (10 mg/ml).
CLINICAL RELEVANCE
This research may contribute to better understanding of mechanisms of inflammation and chronic infection in cystic fibrosis (CF). The enzyme arylsulfatase B, which appears to have extra-lysosomal localization, modifies chondroitin sulfation, leading to reduced secretion of IL-8 and retention of IL-8 by bronchial epithelial cells. Better understanding of these mechanisms may help to explain the pathophysiology of CF and improve therapeutic interventions.
LHC-8 medium without phenol red (Biosource, Invitrogen, Carlsbad, CA) supplemented with 5% FBS (Gibco, Invitrogen) was used as growth medium, and cells were maintained in a 5% CO 2 environment at 378C, as previously described (8) (9) (10) (11) (12) (13) . Primary, normal human bronchial/tracheal epithelial cells were obtained (Clonetics NHBE with retinoic acid; Lonza, Walkersville, MD) and grown in the recommended BEC growth media (BEGM; Lonza) following established procedures.
Cells reached 80% confluence and were subcultured after harvesting with 0.25% (wt/vol) trypsin, 0.53 mM EDTA solution (Sigma-Aldrich) or ReagentPack Subculture Reagents (Lonza). Spent media were collected, and cell homogenates or lysates were processed for measurements of sulfatase activity, protein content, sGAGs, and other assays. Cells were exposed to TNF-a (Sigma-Aldrich), 1 ng/ml 3 24 hours.
Immunocytochemistry and Confocal Microscopy
Cells were grown on coated chamber slides for 48 hours, then fixed with 95% EtOH for 30 minutes and stained with rabbit polyclonal ASB antibody at a 1:50 dilution (Open Biosystems, Huntsville, AL), rinsed in buffer, and incubated with mouse anti-rabbit secondary antibody. Slides were rinsed in buffer, then treated with 3,39-diaminobenzidine for color detection, rinsed in H 2 O, dehydrated, coverslipped with permount, and photographed with a Nikon imaging system (Nikon, Tokyo, Japan). No enhancement or modification of the images was performed.
For confocal microscopy, the BEC were grown in four-chamber tissue culture slides for 24 hours, silenced with small interfering RNA (siRNA) or control siRNA for 24 hours, then fixed in 2% paraformaldehyde for 1.5 hours. Cells were washed three times in 13 PBS containing 1 mM calcium chloride (pH 7.4), permeabilized with 0.08% saponin, and blocked with 5% normal goat serum for 1 hour. Cells were then incubated for 1 hour with ASB polyclonal antibody (Open Biosystems) at room temperature, washed, and stained with goat antirabbit Alexa Fluor IgG 568 (1:100; Invitrogen) and Alexa Fluor Phalloidin 488 (1:60; Invitrogen) for 1 hour. Preparations were washed thoroughly, mounted with DAPI mounting medium (ActiveMotif, Carlsbad, CA), and observed using a Zeiss LSM 510 laser scanning confocal microscope with excitation at 488 nm and 534 nm (Zeiss, Thornwood, NY) from an Ar/Kr laser and at 361 nm from an ultraviolet laser. Green (F-actin) and red (ASB) fluorescence were detected through LP505 and 585 filters; nuclei were stained blue. Orthogonal images were obtained after detection of the top and bottom of the cell monolayer. The fluorochromes were scanned sequentially, and the collected images were exported with Zeiss LSM Image Browser software as TIFF files for analysis and reproduction.
Determination of IL-8 by ELISA
The secretion of IL-8 in the spent media or cell preparation of control and treated cells was measured by using the Duoset ELISA kit for human IL-8 (R&D Systems, Minneapolis, MN), with a range of detection from 31.2-2,000 pg/ml, and a sensitivity of 1.5-7.5 pg/ml, as reported previously (14) . The IL-8 concentrations were extrapolated from a standard curve plotted by using known concentrations of IL-8.
The sample values were normalized with total cell protein content (BCA protein assay; Pierce, Thermo Scientific, Rockford, IL) and expressed as picograms per milligram cell protein.
IL-8 content of cell lysates was also determined. Cell lysates were prepared in RIPA buffer (50 nM Tris-HCl containing 0.15 M NaCl, 1% Nonidet P40, 0.5% deoxycholic acid, and 0.1% SDS [pH 7.4]), and microcentrifuged at 14,000 rpm for 10 minutes at 48C. The clear supernatant was used as the cell lysate. The IL-8 content of IB3-1, C38, and BEC after immunoprecipitation with C4S antibody or cell fractionation (see below) was also measured by this ELISA.
ASB Activity Assay
ASB measurements were performed using a fluorometric assay, following a standard protocol with 20 ml of cell homogenate, 80 ml of assay buffer (0.05 M Na-acetate buffer [pH 5.6]), with 100 ml of substrate (5 mM 4-MUS in assay buffer) combined in a microplate well, as reported previously (8, 15, 16) . Galactose-6-sulfatase (GALNS) assay was performed using, as substrate, 10 mM 4-methylumbilliferylb-D-galactoside-6-sulfate NH 4 (MU-bGal-6S; Moscerdam, Rotterdam, The Netherlands), as previously reported (15) .
Silencing ASB by siRNA siRNA to silence ASB was obtained commercially (Qiagen, Valencia, CA) and tested for specific effect on reduction of ASB activity. For ASB (NM_000046) silencing, the siRNA sequences were: sense, 59-GGG UAUGGUCUCUAGGCAtt-39, antisense, 59-UUGCCUAGAGACC AUACCCtt-39. For the negative control, the siRNA sequences were: sense, 59-UUCUCCGAACGUGUCACGUtt-39, antisense, 59-ACGU GACACGUUCGGAGAAtt-39.
ASB siRNA (150 ng; 0.6 ml) in 100 ml serum-free culture medium and 12 ml of HiPerfect Transfection Reagent (Qiagen) were combined by vortexing, maintained at room temperature for 10 minutes, then added drop-wise onto 50-60% confluent cells in a six-well culture plate. Cells were swirled for uniform distribution of the transfection complexes, and were incubated at 378C with 5% CO 2 . Control cells received control siRNA under similar conditions. Subsequently, 24 hours later, the medium was exchanged with fresh media with 5% FBS. After an additional 24 hours, the spent media were collected, and the cells harvested for measurements of sulfatase activity. ASB activity declined from 84.3 (61.5) to 21.5 (61.4) nmol/mg protein/h after silencing by siRNA (P , 0.001) in the C38 cells, with no change in GALNS activity (2.36 6 0.13 to 2.34 6 0.13 nmol/mg protein/h) or iduronate sulfatase activity (40.5 6 2.1 to 39.0 6 1.0 nmol/mg protein/h) in the C38 cells, confirming specificity of the silencing. Similar responses occurred in the IB3-1 cells. Decline in density and intensity of immunostaining for ASB was also observed, consistent with the enzyme activity data.
Silencing Galactose-6-Sulfatase by siRNA siRNA for GALNS was obtained commercially (Qiagen) and tested for specific effect on reduction of GALNS activity. Methods for GALNS silencing and for detection of GALNS activity were published previously (8, 15, 16) . Effectiveness of GALNS silencing was confirmed by activity assay that demonstrated decline in activity from a baseline of 2.33 (60.11) to 0.66 (60.04) nmol/mg protein/h in the C38 cells, and from 2.11 (60.07) to 0.59 (60.05) nmol/mg protein/h in the IB3 cells-declines of over 72%.
Measurement of sGAGs
Total sGAG content, including C4S, C6S, keratan sulfate, dermatan sulfate, heparan sulfate, and heparin, was measured in cell lysates by sGAG assay (Blyscan; Biocolor Ltd., Newtownabbey, Northern Ireland), using the cationic dye, 1,9-dimethylmethylene blue, which reacted with the sGAG to produce a dye-GAG complex (17) . This assay detected the sGAG, whereas degraded disaccharide fragments, unsulfated GAG, and hyaluronan were not detected. The cationic dye and GAG at acid pH produced an insoluble dye-GAG complex, and the GAG content was determined by the amount of dye recovered from the test sample after exposure to blyscan dissociation reagent. The ratio of the GAG dye-binding capability to the C4S sulfation level is reported as 1.0 for C4S from bovine trachea (17) . Absorbance maximum of 1,9-dimethylmethylene blue is 656 nm. Concentration is expressed as micrograms per milligram protein of cell lysate.
Isolation and Purification of GAGs from IB3-1 and C38 Cells
Cell samples were homogenized in 0.5 ml water and freeze dried. The freeze-dried cell samples were defatted with CHCl 3/ MeOH solvent (2:1, 1:1, 1:2 [vol/vol], respectively). Dried cell samples were individually subjected to proteolysis at 558C with 10% actinase E (20 mg/ml; Kaken Biochemicals, Tokyo, Japan) for 18 hours. After proteolysis, dry urea (Sigma Chemical Co., St. Louis, MO) and dry CHAPS (Sigma) were added to each sample (2 weight/vol % in CHAPS and 8 M in urea). A Vivapure MAXI Q H spin column (Viva Science, Edgewood, NJ) was prepared by equilibrating with 0.5 ml of 8 M urea containing 2% CHAPS (pH 8.3). The clarified filtered samples were loaded onto and run through the Vivapure MAXI QH spin columns under centrifugal force (500 3 g). The columns were first washed with 0.5 ml of 8 M urea containing 2% CHAPS at pH 8.3. The columns were then washed five times with 1 ml 200 mM NaCl. GAGs were released from the spin column by washing three times with 0.2 ml of 16% NaCl. Methanol (3 ml) was added to the GAG solution in sodium chloride to afford an 80 vol/vol % solution, and the mixture was equilibrated at 48C for 18 hours. The resulting precipitate was recovered by centrifugation (2,500 3 g) for 15 minutes. The precipitate was recovered by dissolving in 0.5 ml of water, and the recovered GAGs were stored frozen for further analysis. Unsaturated disaccharide standards of chondroitin sulfate and
, and Di-triS DUA2S-GalNAc4S6S) and unsaturated disaccharide standards of heparin and heparan sulfate (Di-0S DUA-GlcNAc, Di-NS DUA-GlcNS, Di-6S DUAGlcNAc6S, Di-UA2S DUA2S-GlcNAc,Di-UA2SNS DUA2S-GlcNS, Di-NS6S DUA-GlcNS6S, Di-UA2S6S DUA2S-GlcNAc6S, and Di-triS DUA2S-GlcNS6S) were obtained from Seikagaku (Tokyo, Japan).
Disaccharide Composition Analysis Using Liquid Chromatography-Mass Spectrometry
Enzymatic depolymerization of GAG samples (20 mg/5 ml) was performed by incubation with chondroitinase ABC (10 mU; Seikagaku) and chondroitinase ACII (5 m-units; Seikagaku) at 378C for 10 hours. The enzymatic products were recovered by centrifugal filtration (YM-3, 3,000 MWCO; Millipore, Bedford, MA). CS/DS disaccharides passed through the filter were freeze dried and ready for liquid chromatography-mass spectrometry (LC-MS) analysis. Next, the heparinase I, II, and III (5 m-units each; Seikagaku) were added into the remainder, and incubated at 378C for 10 hours. The products were again recovered by centrifugal filtration and the heparin/HS disaccharides were similarly collected and freeze dried and ready for LC-MS analysis. The LC-MS analysis was performed on an LC-MS system (LC/MSD trap MS; Agilent, Santa Clara, CA). Solutions A and B for high-pressure liquid chromatography were 15% and 65% acetonitrile, respectively, containing the same concentration of 37.5 mM NH 4 HCO 3 and 11.25 mM tributylamine. The pH values were adjusted to 6.5 with acetic acid, and the flow rate was 10 ml/min. The separation was performed on a C-18 column (Agilent) using solution A for 20 minutes, followed by a linear gradient from 20 to 45 minutes of 0-50% solution B. The column effluent entered the source of the electrospray ionization mass spectrometry (ESI-MS), for continuous detection by MS. The electrospray interface was set in negative ionization mode with the skimmer potential of 400 V, capillary exit of 240.0 V, and a source of temperature of 3258C, to obtain maximum abundance of the ions in a full-scan spectrum (150-1,500 Da, 10 full scans/s). Nitrogen was used as a drying (5 liters/min) and nebulizing gas (20 psi).
Immunoprecipitation of Cell Lysates by C4S Antibody
Cell lysates were prepared (as detailed above) from cells that were treated with siRNA for ASB and control siRNA, and with or without exposure to TNF-a. C4S antibody (4D1; Santa Cruz Biotechnology, Santa Cruz, CA) detects C4S, not chondroitin sulfate E (CSE), C6S, or the chondroitin stubs. Yield of pure C4S by this method was over 90%, whereas recovery of pure CSE or C6S in a 90:10 mixture of C6S/C4S was , 10%. The specificity of the C4S antibody was reported previously (16, 18) . There was no prior enzymatic digestion by chondroitinase (16, 18, 19) . The antibody was added to the cell lysates in tubes at a concentration of 2 mg/mg protein, and tubes were rotated overnight in a shaker at 48C. Next, 100 ml of prewashed protein L-agarose (Santa Cruz Biotechnology) was added to each tube, and the tubes incubated overnight at 48C. The protein L-agarose-conjugated beads were washed three times with PBS-containing protease inhibitor cocktail (Pierce). The precipitate was eluted with dye-free elution buffer and subjected to sGAG assay.
Measurement of NF-kB by Nuclear Oligonucleotide ELISA
Nuclear extracts were prepared from treated and control cells using a nuclear extraction kit (ActiveMotif). Activated NF-kB in the samples was determined by oligonucleotide-based ELISA (ActiveMotif), as described previously (20) . Treated and control samples were added and incubated in 96-well microtiter wells, and the activated NF-kB in the nuclear extracts attached to a consensus nucleotide sequence (59-GGG ACTTTCC-39) that was coated onto the microtiter wells (21) . The specificity of the binding of NF-kB of the samples was determined by comparison to the binding in the presence of either free consensus nucleotide or mutated nucleotide.
Cell Fractionation
Cells were harvested in PBS containing 2 mM EDTA, disrupted by sonication in ice-cold sonication buffer (20 mM Tris-HCl [pH 7.5], 0.25 M sucrose, 10 mM MgCl 2 , and 2 mM EDTA) with a complete protease inhibitor mixture, then centrifuged at 10,000 3 g for 10 minutes at 48C (22) . The pellet was discarded, and the resulting supernatants were centrifuged at 100,000 3 g for 1 hour at 48C. The resulting pellet (membrane fraction) was solubilized in RIPA buffer (50 nM Tris-HCl containing 0.15 M NaCl, 1% nonidet P40, 0.5% deoxycholic acid, and 0.1% SDS [pH 7.4]). IL-8, protein, and ASB activity were measured in the supernatant (cytosol) and in the membrane fractions, as described above.
Polymorphonuclear Leukocyte Migration Assay
Pooled, deidentified, citrated whole blood (25 ml) was collected from clinical laboratory samples, in accord with an approved protocol. The sample was diluted twofold with normal saline, and layered over a Ficoll hypaque gradient (density, 1.077; BioWhittaker, Walkersville, MD), and spun at 400 3 g for 30 minutes. The polymorphonuclear (PMN) leukocyte-rich fraction was removed, and contaminating red blood cells were lysed with hypotonic saline. The PMN were washed twice with normal saline and then resuspended in 5.0 ml RPMI 1,640 without phenol red (Invitrogen), containing 10% heat-treated FCS (HyClone, Logan, UT).
Calcein-AM (5 mg/ml; Sigma-Aldrich) was added to the 5.0-ml suspension of cells in RPMI-FCS, and the cells were incubated for 30 minutes at 378C (23) . Neutrophils were washed twice with normal saline, counted in a counting chamber, and resuspended in RPMI-FCS to the desired concentration of 12,000 cells/ml.
Disposable 96-well chemotaxis chambers (ChemoTx; Neuro Probe, Gaithersburg, MD) were used to detect neutrophil (PMN) migration (24) . The filters for the 96-well plate were 3.2-mm in diameter, yielding a filter area of 8 mm 2 per site, with pore size of 3 mm. The wells of the microplate were filled with 29 ml of IB3-1 or C38 cell homogenate or spent media. The polycarbonate filters were positioned on the loaded microplate and secured in place with corner pins. PMN suspensions (25 ml) were placed directly into the filter sites, and the microplate was incubated for 1 hour (378C and 5% CO 2 ). The nonmigrating cells on the top of the filter were removed by gently wiping the filter with a tissue. The microplate was placed in a multiwell fluorescent plate reader (FL600; Bio-Tek Instruments, Inc., Winooski, VT), and the cells that migrated into the bottom chamber were detected and measured by using the calcein fluorescence signal. The fluorescent plate reader was configured so that the probe was in a bottom-read position, which allowed for the detection of fluorescence in each well of the chemotaxis chamber (excitation, 485 nm; emission, 530 nm).
Statistical Analysis
All experiments were performed in at least triplicate biological samples with technical replicates. P values less than 0.05 were considered significant. Unless stated otherwise, the statistical significance was determined using one-way ANOVA, with Tukey-Kramer post-test for multiple comparisons. Measurements presented are the mean (6SD) of at least three independent determinations.
RESULTS
Effect of ASB Silencing by siRNA on Enzyme Activity
After ASB silencing by siRNA, ASB activity declined approximately 75% in the cell homogenates, from 54.9 (60.4) to 13.0 (61.0) nmol/mg protein/h in the IB3-1 cells (CFTR uncorrected), from 83.9 (61.1) to 21.5 (61.4) nmol/mg protein/hour in the C38 cells (CFTR-corrected), and from 70.1 (65.6) to 16.1 (61.7) nmol/mg protein/hour in the BEC (P , 0.001). TNF-a exposure (1 ng/ml 3 24 h) had no impact on ASB activity, either at baseline or after ASB silencing. Cell fractionation into cytosol and membrane fractions demonstrated that ASB activity was several-fold greater in the membrane fraction in the IB3-1 ( Figure 1A ) and in the C38 (Figure 1B ) cells. Baseline ASB activity in the CFTR-corrected C38 BECs was 1.53 times the value in the CFTR-uncorrected IB3-1 cell line, and was similar to previous findings (8) . Immunocytochemistry for ASB demonstrated the difference in intensity of ASB staining between IB3-1 ( Figure 1C ) and C38 ( Figure 1D ) cells. In addition, the images suggested possible localization of ASB along the cell periphery. Membrane localization of ASB was also evident in the section of normal human lung tissue stained for ASB ( Figure 1E ) compared with the negative control stain ( Figure 1F ).
Confocal microscopy confirmed the impression of ASB staining along the cell membrane ( Figure 1G ), because red fluorescence of ASB was evident at the cell surface in the z-stack (xz and yz) orthogonal images. Surface ASB was particularly notable in the yz images. Also, in the confocal images that demonstrated the effectiveness of ASB silencing ( Figures 1H and 1I [control siRNA] versus Figures 1J and 1K [ASB siRNA]), ASB staining was evident at the cell periphery. These images indicated that ASB had extralysosomal localization at the cell membrane in BECs.
ASB Silencing Inhibited the TNF-a-Induced Increase in IL-8 Secretion
Unstimulated, IL-8 secretion was 104 (612) pg/mg protein in the IB3-1 cells (Figure 2A ). After exposure to TNF-a (1 ng/ml 3 24 h), IL-8 secretion increased to 1,295 (635) pg/mg protein.
When cells were exposed to TNF-a after ASB silencing by siRNA, the TNF-a-induced IL-8 secretion declined significantly, to 706 (630) pg/mg protein (P , 0.001). In contrast, silencing of GALNS by siRNA had no effect on IL-8 secretion, and the combined effect of ASB siRNA and GALNS siRNA produced no further decline in IL-8 secretion. A similar pattern of responses was demonstrated in the C38 cells ( Figure 2B) . However, the peak IL-8 response to TNF-a stimulation was less, consistent with a greater inflammatory response in CF than non-CF cells. Similarly, in the BEC, IL-8 secretion declined from 997 (661) to 410 (630) pg/mg protein after ASB silencing, consistent with the reductions of over approximately 550 pg/mg protein in the IB3-1 and C38 cell lines.
NF-kB Activation Unchanged by ASB Silencing
To clarify whether the decline in IL-8 secretion in response to TNF-a that followed ASB silencing could be explained by a decline in NF-kB activation, NF-kB (p65) was measured by an oligonucleotide ELISA in the IB3-1 ( Figure 2C ) and C38 ( Figure 2D ) cells. ASB silencing had no effect on NF-kB activation, indicating that an event downstream of NF-kB activation was responsible for the decline in IL-8 secretion after ASB silencing. ) activity was localized predominantly in the cell membrane in the IB3-1 and C38 cells, and declined approximately 75% after knockdown by small interfering RNA (siRNA). When ASB activity was measured in membrane and cytosolic fractions after cell fractionation, ASB activity in the membrane was several fold greater than in the cytosol in the IB3-1 (A) and C38 (B) cells (closed bars, ASB si; gray bars, Cn si). The predominant membrane activity is consistent with the pattern of immunostaining. In the IB3-1 cells (C ), the intensity of immunostaining (brown) is much less than in the C38 cells (D). ASB immunostaining appears in the cell membrane, as well as in the cytoplasm, suggesting more widespread localization than in the lysosomes. Prominent staining of ASB is detected in human lung tissue (E ), both in the cytoplasm and along the cell periphery. (F ) negative control. Confocal microscopy demonstrates the presence of ASB (red fluorescence) at the surface of the cells, as seen best in the yz-stack images (G). Nuclei are imaged in blue (DAPI stain) and F-actin is green. The effectiveness of ASB silencing is demonstrated by the decline in red staining after knockdown Control siRNA (H and I ) versus ASB siRNA ( J and K). ASB si, ASB siRNA; Cn si, control siRNA; IB3, IB3-1.
ASB Silencing Increased IL-8 Concentration in Cell Extracts with No Change in Total IL-8
Because the activation of NF-kB was unaffected by ASB silencing, reduced IL-8 stimulation by NF-kB could not explain the decline in IL-8 secretion that followed ASB silencing. When IL-8 content of the cell extracts was measured, it was apparent that the cell-bound IL-8 content had increased three to four times the baseline value after ASB silencing (P , 0.001) in the IB3-1 (Figure 3A) , the C38 ( Figure 3B ), and the primary BEC ( Figure 3C ). Total IL-8, including secreted and cell-bound IL-8, did not change after ASB silencing.
To determine the intracellular distribution of the cell-bound IL-8, cell fractionation was performed, and the IL-8 content associated with the membrane and the cytosolic fractions was measured. IL-8 content after TNF-a stimulation, but without . ASB silencing reduced IL-8 secretion, but had no effect on NF-kB production. TNF-a exposure (1 ng/ml 3 24 h) produced marked increases in IL-8 secretion by the IB3-1 (A), C38 (B), and bronchial epithelial cells (BEC) (data not shown). Silencing ASB markedly reduced these increases. In contrast, silencing galactose-6-sulfatase (GALNS) had no effect on IL-8 secretion in either cell line. Closed bars, without TNF; gray bars, with TNF. Cn, control. To determine if the difference in IL-8 secretion was attributable to an effect upstream or downstream of NF-kB, activated NF-kB was measured by an oligonucleotide ELISA. NFkB increased approximately fivefold after TNF-a exposure (P , 0.001), and was approximately 15% greater in the IB3-1 cells (C ) than in the C38 cells (D). Knockdown of ASB had no effect on the NF-kB activation in either cell line, indicating that the decline in IL-8 secretion in both cell lines after ASB silencing was due to an effect downstream of NF-kB activation. ***P , 0.001. ASB silencing, was greater in the cytosolic fraction than in the membrane fraction in the IB3-1 (Figure 4A ), the C38 ( Figure  4B ), and the BEC ( Figure 4C ) (P , 0.001). After ASB silencing, the IL-8 content in the membrane fraction was significantly increased, to about two times that of the cytosolic fraction (P , 0.001), consistent with membrane trapping of IL-8.
Differences in Total sGAG and C4S Content before and after ASB Silencing
Baseline total sGAG was 19.7 (61.4) mg/mg protein in the IB3-1 cells (Figure 5A ), 14.0 (61.1) mg/mg protein in the C38 cells ( Figure 5B ), and 11.7 (60.3) mg/mg protein in the BEC. After ASB silencing, these values increased by 8.2, 9.8, and 9.6 mg/mg protein, respectively (P , 0.001). These increases were largely attributable to increased sulfation of C4S; C4S content increased 7.6 ( Figure 5C ), 9.7 ( Figure 5D ), and 8.6 mg/mg protein, respectively (P , 0.001). TNF-a exposure did not affect these values.
LC-MS Detection of Differences in C4S and C6S Content after ASB Silencing
After ASB silencing, the IB3-1 and the C38 cells have different C4S and C6S composition, as presented in the chromatograms ( Figure 6A ). The retention times of the 4S and 6S peaks, while very close, are distinctly different, with 4S eluting before 6S. The 2S disaccharide is also present, and has the same retention time as the C4S disaccharide. This analysis is made more difficult as the 2S, 4S, and 6S disaccharides have identical masses. The ratio of the peak areas for 4S/2S to 6S for the IB3-1 cells treated with control siRNA was 34.9%:43.0%; the ratio changed to 57.4%:22.3% after ASB silencing. Similarly, the ratio of the peak areas for 4S/2S to 6S for C38 treated with control siRNA was 33.3%:43.1%; the ratio changed to 44.6%:33.6% after ASB silencing. These results confirm a marked change in C4S disaccharide content after ASB silencing.
Separate analysis of the heparin/HS disaccharides revealed no changes after ASB silencing ( Figure 6B) , consistent with the lack of effect of ASB on sulfate groups of heparin or HS. 
Increase in Cell-Associated IL-8 after ASB Knockdown Is Attributable to Increase in IL-8 that Coimmunoprecipitates with C4S
To determine whether the increase in the cell-associated IL-8 was attributable to IL-8 interaction with C4S, cell extracts were immunoprecipitated with the C4S monoclonal antibody, and the IL-8 content of the immunoprecipitates was measured by ELISA in the IB3-1 ( Figure 7A ), the C38 ( Figure 7B ), and the BEC ( Figure 7C ). After TNF-a, but without ASB silencing, the IL-8 content associated with the C4S immunoprecipitate was approximately 50% of the total IL-8 associated with the cell extract. After ASB silencing, the IL-8 associated with the C4S immunoprecipitate increased significantly (P , 0.001), to approximately 80-90% of the total cell-bound IL-8. These increases in the C4S-associated IL-8 can account for the observed decline in IL-8 secretion that followed ASB silencing.
Effect of ASB Silencing and IL-8 Sequestration on Neutrophil Chemotaxis
Migration of neutrophils to the IB3-1 ( Figure 8A ) and to the C38 ( Figure 8B ) cell extracts and spent media was evaluated by assay of neutrophils labeled with calcein-AM. Neutrophil fluorescence was measured in the IB3-1 and C38 cell extracts and spent media, before and after stimulation with TNF-a (1 ng/ml 3 24 h), and after silencing of ASB or exposure to control siRNA. Unstimulated, cell extracts and spent media had low IL-8 content and induced migration of 5% or less of the approximately 12,000 neutrophils that were labeled and introduced into each well. In contrast, the neutrophil migration increased after TNF-a stimulation in the cell extracts (to 12% for IB3-1 and to 8% for C38 cells) and in the spent media (to 62% for IB3-1 and to 42% for C38 cells; P , 0.001). After ASB silencing, the neutrophil migration to the cell extracts was markedly increased (to 38% for IB3-1 and to 34% for C38 cells), and declined in the spent media (to 35% for IB3-1 and to 17% for C38 cells; P , 0.001). Hence, the cell extracts in which ASB was silenced stimulated significantly greater neutrophil migration (3.1 and 4.2 times) than in the control silenced IB3-1 and C38 cells. The chemotaxis induced by the spent media was markedly reduced, to 0.56 times the baseline for the IB3-1 cells and to 0.40 times the baseline for the C38 cells, after ASB silencing. This result was consistent with reduced IL-8 secretion, due to increased cell-bound IL-8 in association with increased C4S. In addition, the results demonstrate greater neutrophil responses to the CF (IB3-1) cells, consistent with the increased inflammation present in CF compared with normal bronchial epithelium.
Summary of the Effects of ASB Silencing and TNF-a Stimulation on IL-8 and on C4S
IL-8 values are presented in Table 1 , including secreted, cellbound, C4S-associated, cell membrane-associated, and cell cytosol-associated IL-8, after control siRNA and ASB siRNA, with and without TNF-a stimulation in the IB3-1, C38, and BEC. The effects of ASB silencing on increasing cell-bound IL-8 were present even without TNF-a stimulation, but were much more apparent when IL-8 production was greater. Table 2 presents the increases in total sGAG and C4S that followed ASB silencing.
DISCUSSION
Profound, inborn deficiency of the enzyme, ASB, leads to the mucopolysaccharidosis (lysososmal storage disease), known as Maroteaux-Lamy syndrome (mucopolysaccharidosis VI), in which there is accumulation of sulfated polysaccharides and severe congenital disease, leading to growth failure, anatomic malformations, systemic illness, and reduced lifespan (25) . Another congenital disorder, CF, is also associated with accumulation of sulfated polysaccharides in the respiratory and gastrointestinal tracts, although the genetic defect is deficiency of the CFTR. In our evaluation of sulfatase activity in CF cell lines, we found evidence that the activity of ASB was reduced in Figure 5 . ASB silencing increased sulfated glycosaminoglycan (sGAG) and chondroitin-4-sulfate (C4S) content. Total sGAG content increased significantly in the IB3-1 (A), the C38 (B), and the BEC (not shown) after ASB knockdown (P , 0.001). After immunoprecipitation with C4S antibody, the sGAG content was measured in the cells, with or without ASB silencing, and with or without TNF-a stimulation. In the IB3-1 cells, the C4S content increased approximately 7.7 mg/mg protein (C ), approximately 9.7 mg/mg protein in the C38 cells (D), and 8.6 mg/mg protein in the BEC (data not shown). TNF-a exposure had no effect on the total sGAG or C4S content. The increases in the C4S content account in large part for the increase in total sGAG, and were statistically significant (***P , 0.001). Closed bars, with TNF; gray bars, without TNF.
CF cells, and increased after correction of CFTR deficiency by genetic manipulations (8) . Recent evaluation of clinical samples demonstrated reduction in ASB activity in peripheral leukocytes of children with CF compared with healthy controls (7) . In other work, we found reduced activity of ASB in malignant human mammary cell lines and malignant human mammary tissue compared with normal human mammary cells (15) . In experiments with the malignant mammary cell line, MCF-7, silencing ASB was associated with increased content of cellular sGAG, largely attributable to increase in C4S. Inversely, overexpression of ASB provoked decline in sGAG and increases in syndecan-1 and decorin expression (16) . These findings suggest that modification of ASB activity may have functional significance in human cells, and that changes in activity of sulfatase enzymes may have ramifications for human pathophysiology, beyond that associated with the congenital mucopolysaccharidoses.
To further consider the impact of ASB modifications on C4S, we undertook the experiments reported in this article. This work was performed in the context of the finding that ASB activity appears reduced in patients with CF, as well as in CF cell lines, and that chondroitin sulfate is increased. The major finding shown by the experiments reported in this article is that, after ASB silencing, cell-bound IL-8 increased in association with the increase in C4S. In the cells studied, the total IL-8 production did not decline after ASB silencing, but IL-8 secretion declined.
Because neutrophil attraction to cell extracts from the C38 and IB3-1 cells increased, and neutrophil chemotaxis to the spent media declined after ASB silencing, the associated changes in C4S that impact on IL-8 distribution may have profound effects on the inflammatory response. Although the experiments that were performed were not designed to demonstrate altered attachment of the human neutrophils to the BECs after ASB silencing, they suggest that increased C4S impacts on IL-8 release, thereby modifying neutrophil responses. These findings may have significant implications for the pathophysiological processes found in CF, in which there is adherence of an inflammatory infiltrate to the bronchial epithelium, producing the biofilm and refractory infection.
The chemotactic response of neutrophils to a gradient established by secreted IL-8 may be impaired when ASB activity is reduced, and neutrophil adherence to the BECs Figure 6 . Liquid chromatography-mass spectrometry (LC-MS) confirms an increase in C4S content after ASB knockdown, and demonstrates no change in heparin or heparan sulfate disaccharides. The peak intensity of C4S/C2S increased after ASB knockdown in both the C38 and IB3 cells (A). The relative proportion of the C4S/C2S peak is increased, in contrast to the C6S peak, which is less prominent, after ASB silencing. No changes in the intensity of the heparin or heparan sulfate disaccharides were evident after silencing of ASB (B). When the area under the curves was compared, the percentage of C4S was increased in both the IB3-1 and C38 cells. may be increased. Because silencing GALNS did not lead to decline in IL-8 secretion, the chondroitin sulfate-IL-8 association appears to be specific to the 4-sulfation of C4S, rather than to the 6-sulfation of C6S. The increase in C4S, rather than C6S, after ASB silencing, is demonstrated by both the quantitative analysis of C4S content after ASB silencing by mass spectrometry and the measurement of sGAG immunoprecipitated by C4S antibody. ASB activity, as reflected in C4S sulfation, may regulate IL-8 binding and trafficking. Because the assay used to measure C4S detects sulfation, the data demonstrate the association of cell sequestration of IL-8 with C4S sulfation.
The finding that knockdown of ASB by siRNA markedly reduced IL-8 secretion in response to TNF-a stimulation in the BEC lines was unexpected. The ASB activity of the CF cells (IB3-1) is less than when CFTR is corrected (C38 cells), but the IL-8 production and secretion is greater in the CF cells. The explanation for this is beyond the scope of this article, but appears, from preliminary experiments, to be attributable to increased production by the C38 cells of soluble TNFRII, an inhibitor of TNF-a interaction with its receptor.
Concomitant with the reduction in the secreted IL-8 chemotactic gradient after ASB silencing is the potential for increased neutrophil adherence to the sequestered, membrane-localized IL-8. The phenomenon of haptotaxis has been linked to the sequestration of IL-8 by chondroitin sulfate in lung cells, and may be critical in the development of the inflammatory response (2-4). Hence, the increases in cell-associated IL-8 and neutrophil haptotaxis that followed ASB reduction by siRNA may have relevance in vivo, and help to explain the increased adherence of inflammatory cells to CF cells that have lower ASB activity and higher C4S and IL-8 content. Certainly, other factors may be of considerable importance, such as reduction in the bactericidal capacity of the CF neutrophils, due to proteolytic cleavage of the CXCR1 IL-8 receptor on the neutrophils (26) . In vivo, the endogenous, relative reduction of ASB activity in CF cells may affect the retention of IL-8 by BECs and the adherence of neutrophils in an inflammatory infiltrate. Accumulation of neutrophils is a well established characteristic of CF-associated lung disease (27, 28) , in which the inflammatory response may be more intense than in non-CF cells (29) .
The Pseudomonas aeruginosa-associated biofilm is a characteristic of CF lung disease (30, 31) . It is pertinent to note that P. aeruginosa has well recognized requirements for sulfate for growth, and has sulfatase activity (32) . These features suggest that the sulfate-enriched milieu associated with reduced ASB activity may favor the growth of Pseudomonas in CF. In addition, the increased GAG sulfation in association with Neutrophil migration showed increased response to cell extract and reduced response to spent media after ASB silencing, consistent with the observed increases in cell-associated C4S and IL-8. Neutrophil migration to the cell extract and spent media of the IB3-1 (A) and C38 (B) cells was measured by changes in fluorescence of calcein-AM-labeled, pooled human neutrophils. IB3-1 and C38 cells were treated with control siRNA or ASB siRNA for 24 hours, then exposed (or not exposed) to TNF-a (1 ng/ml 3 24 h). Data are the mean (6SD) of three independent experiments, calculated as the percentage of the fluorescence associated with labeling of approximately 12,000 neutrophils/ml (300,000 neutrophils/25 ml). After ASB silencing, the neutrophil migration toward the cell extracts increased, and migration toward the spent media declined (P , 0.001). Neutrophil migration was greater toward the spent media and the cell extract of the cystic fibrosis (IB3-1) cells. Closed bars, ASB si; gray bars, control si. ***P , 0.001. reduced ASB activity may impose an anionic load on the BECs, requiring cations to adhere to the cell surface, and favoring development of tenacious secretions, as in the biofilm (4, 29, 30) .
Because IL-8 is a critically important chemokine, participating in neutrophil chemotaxis and potentiating the inflammatory response in mammalian tissues, the findings of this study may help in our understanding of the mechanisms that produce the chronic inflammation found in CF. Retention of IL-8 in association with increased sulfation of C4S suggests that the chemotactic response of neutrophils to a gradient established by secreted IL-8 is impaired when ASB activity is reduced, and that neutrophil adherence to epithelial cells is increased. The impact of reduced IL-8 secretion and increased cell-bound IL-8 on vital cellular interactions and cellular responses requires further study. Further consideration of the role of decline in ASB activity may help to integrate the sulfatase metabolic pathways into basic mechanisms of intra-and intercellular signaling and of inflammation. 
